Discover 2,413 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,413
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Bethesda MD, Philadelphia PA, New Brunswick NJ,
Sponsor: CellCentric Ltd.
Sex: All
Age: 18+
Code: NCT07096778
Phase2, Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for
Breast Neoplasms, Neoplasm Metastasis
Location: Bethesda MD, Washington D.C. DC, Frederick MD,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07174336
Phase3, Recruiting
Testing Adaptive Physical Activity in Stroke
for
Stroke
Location: Baltimore MD
Sponsor: Baltimore VA Medical Center
Sex: All
Age: 40+
Code: NCT01042990
Recruiting
Treatment of Type 2 Diabetes With Ketogenic Diet
for
Type2 Diabetes Mellitus, Obesity
Location: Bethesda MD
Sponsor: Mid-Atlantic Epilepsy and Sleep Center, LLC
Sex: All
Age: 18 - 70
Code: NCT03652649
Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for
Proteinuric Kidney Disease
Location: Washington D.C. DC, Gaithersburg MD, Oxon Hill MD,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 10 - 65
Code: NCT05312879
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
for
Early Breast Cancer
Location: Washington D.C. DC, Silver Spring MD, Baltimore MD,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT05827081
Phase3, Recruiting
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
for
Viral Lung Infection and Acute Respiratory Failure
Location: Washington D.C. DC, Annapolis MD, Charlottesville VA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05624450
Phase3, Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
for
Intracranial Meningioma, Recurrent Meningioma,
Location: Fairfax VA, Baltimore MD, Hershey PA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT02523014
Phase2, Recruiting
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
for
Hypogammaglobulinemia, Bacterial Infections,
Location: Bethesda MD, Wilson NC, Greenville NC, Morrisville NC,
Sponsor: Grifols Therapeutics LLC
Sex: All
Age: 18+
Code: NCT05645107
Phase3, Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for
Geographic Atrophy, Macular Degeneration
Location: Chevy Chase MD, Baltimore MD, Hagerstown MD, Norfolk VA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 60+
Code: NCT06635148
Phase2, Phase3, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Washington D.C. DC, Baltimore MD, Frederick MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase2, Phase3, Recruiting
Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
for
Carcinoma, Squamous Cell
Location: Baltimore MD, Columbia SC, Louisville KY, Dallas TX,
Sponsor: Introgen Therapeutics
Sex: All
Age: 18+
Code: NCT00041613
Phase3, Recruiting
Reiterative Development and Evaluation Study of OSA Therapy System
for
Obstructive Sleep Apnea
Location: Chevy Chase MD, Columbia SC, Louisville KY, Atlanta GA,
Sponsor: ApniCure, Inc.
Sex: All
Age: 18 - 70+
Code: NCT01634074
Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study